6533b7d4fe1ef96bd126294d

RESEARCH PRODUCT

Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

Cristina BottinAlessandro ZanniniAlessandro ZanniniStefan SchoeftnerStefan SchoeftnerDeborah BonazzaMarina BortulValeria CancilaMariangela SantorsolaMariangela SantorsolaFabrizio ZanconatiGiannino Del SalGiannino Del SalElena CampanerElena CampanerClaudio Tripodo

subject

0301 basic medicineCancer ResearchMechanotransductionBreast cancer; Dasatinib; Drug testing; Heterogeneity; Mechanotransduction; Patient‐derived tumor organoids; Statin; YAPPatient‐derived tumor organoidCellDasatinibDrug resistanceSettore MED/08 - Anatomia PatologicaBiologylcsh:RC254-282Article03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerbreast cancermedicineOrganoidSettore MED/05 - Patologia Clinicadasatinibdrug testingmechanotransductionpatient-derived tumor organoidsGenetic heterogeneitystatinStatinDrug testingBreast cancerDasatinib Drug testing Drug testing Heterogeneity Patient‐derived tumor organoids Statin YAPmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensIn vitroDasatinib030104 developmental biologymedicine.anatomical_structureOncologyCell culture030220 oncology & carcinogenesisCancer researchPatient‐derived tumor organoidsYAPHeterogeneityheterogeneitymedicine.drug

description

Tumor organoids are tridimensional cell culture systems that are generated in vitro from surgically resected patients&rsquo

10.3390/cancers12123869http://dx.doi.org/10.3390/cancers12123869